Narcolepsy Pipeline Review, H2 2018 – Therapeutic Analysis of 13 Companies & Drug Profiles – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Narcolepsy
– Pipeline Review, H2 2018”
drug pipelines has been added to ResearchAndMarkets.com’s
offering.

Narcolepsy – Pipeline Review, H2 2018, provides comprehensive
information on the therapeutics under development for Narcolepsy
(Central Nervous System), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.

The Narcolepsy (Central Nervous System) pipeline guide also reviews of
key players involved in therapeutic development for Narcolepsy and
features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities /Institutes,
the molecules developed by Companies in Pre-Registration, Phase III,
Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 4,
4, 4, 5, 2 and 1 respectively. Similarly, the Universities portfolio in
Preclinical stages comprises 2 molecules, respectively.

Narcolepsy (Central Nervous System) pipeline guide helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Report Coverage
  3. Narcolepsy – Overview
  4. Narcolepsy – Therapeutics Development
  5. Pipeline Overview
  6. Pipeline by Companies
  7. Pipeline by Universities/Institutes
  8. Products under Development by Companies
  9. Products under Development by Universities/Institutes
  10. Narcolepsy – Therapeutics Assessment
  11. Assessment by Target
  12. Assessment by Mechanism of Action
  13. Assessment by Route of Administration
  14. Assessment by Molecule Type
  15. Narcolepsy – Companies Involved in Therapeutics Development
  • Avadel Pharmaceuticals Plc
  • Bioprojet SCR
  • Evotec AG
  • F. Hoffmann-La Roche Ltd
  • H.A.C. Pharma
  • Heptares Therapeutics Ltd
  • Jazz Pharmaceuticals Plc
  • Ono Pharmaceutical Co Ltd
  • OptiNose US Inc
  • SK Biopharmaceuticals Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Theranexus SAS

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vtngnk/narcolepsy?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.